N P Hinds, C E Hillier, C M Wiles. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antidepressive Agents, Tricyclic/administration & dosageAntidepressive Agents, Tricyclic/adverse effectsAntiparkinson Agents/administration & dosageAntiparkinson Agents/adverse effectsDepressive Disorder/drug therapyDrug InteractionsFemaleHumansMiddle AgedNortriptyline/administration & dosageNortriptyline/adverse effectsParkinson Disease/complicationsParkinson Disease/drug therapySelegiline/administration & dosageSelegiline/adverse effectsSerotonin Syndrome/chemically induced
Substances: See more » Antidepressive Agents, TricyclicAntiparkinson AgentsSelegilineNortriptyline
Year: 2000 PMID: 11127542 DOI: 10.1007/s004150070101
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849